Cargando…
Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies
CRMP-5-associated GTPase (CRAG), a short splicing variant of centaurin-γ3/AGAP3, is predominantly expressed in the developing brain. We previously demonstrated that CRAG, but not centaurin-γ3, translocates to the nucleus and activates the serum response factor (SRF)-c-Fos pathway in cultured neurona...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934726/ https://www.ncbi.nlm.nih.gov/pubmed/31882856 http://dx.doi.org/10.1038/s41598-019-56559-9 |
_version_ | 1783483450454441984 |
---|---|
author | Nagashima, Shun Takeda, Keisuke Shiiba, Isshin Higashi, Mizuho Fukuda, Toshifumi Tokuyama, Takeshi Matsushita, Nobuko Nagano, Seiichi Araki, Toshiyuki Kaneko, Mari Shioi, Go Inatome, Ryoko Yanagi, Shigeru |
author_facet | Nagashima, Shun Takeda, Keisuke Shiiba, Isshin Higashi, Mizuho Fukuda, Toshifumi Tokuyama, Takeshi Matsushita, Nobuko Nagano, Seiichi Araki, Toshiyuki Kaneko, Mari Shioi, Go Inatome, Ryoko Yanagi, Shigeru |
author_sort | Nagashima, Shun |
collection | PubMed |
description | CRMP-5-associated GTPase (CRAG), a short splicing variant of centaurin-γ3/AGAP3, is predominantly expressed in the developing brain. We previously demonstrated that CRAG, but not centaurin-γ3, translocates to the nucleus and activates the serum response factor (SRF)-c-Fos pathway in cultured neuronal cells. However, the physiological relevance of CRAG in vivo is unknown. Here, we found that CRAG/centaurin-γ3–knockout mice showed intensively suppressed kainic acid-induced c-fos expression in the hippocampus. Analyses of molecular mechanisms underlying CRAG-mediated SRF activation revealed that CRAG has an essential role in GTPase activity, interacts with ELK1 (a co-activator of SRF), and activates SRF in an ELK1-dependent manner. Furthermore, CRAG and ELK1 interact with promyelocytic leukaemia bodies through SUMO-interacting motifs, which is required for SRF activation. These results suggest that CRAG plays a critical role in ELK1-dependent SRF-c-fos activation at promyelocytic leukaemia bodies in the developing brain. |
format | Online Article Text |
id | pubmed-6934726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69347262019-12-30 Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies Nagashima, Shun Takeda, Keisuke Shiiba, Isshin Higashi, Mizuho Fukuda, Toshifumi Tokuyama, Takeshi Matsushita, Nobuko Nagano, Seiichi Araki, Toshiyuki Kaneko, Mari Shioi, Go Inatome, Ryoko Yanagi, Shigeru Sci Rep Article CRMP-5-associated GTPase (CRAG), a short splicing variant of centaurin-γ3/AGAP3, is predominantly expressed in the developing brain. We previously demonstrated that CRAG, but not centaurin-γ3, translocates to the nucleus and activates the serum response factor (SRF)-c-Fos pathway in cultured neuronal cells. However, the physiological relevance of CRAG in vivo is unknown. Here, we found that CRAG/centaurin-γ3–knockout mice showed intensively suppressed kainic acid-induced c-fos expression in the hippocampus. Analyses of molecular mechanisms underlying CRAG-mediated SRF activation revealed that CRAG has an essential role in GTPase activity, interacts with ELK1 (a co-activator of SRF), and activates SRF in an ELK1-dependent manner. Furthermore, CRAG and ELK1 interact with promyelocytic leukaemia bodies through SUMO-interacting motifs, which is required for SRF activation. These results suggest that CRAG plays a critical role in ELK1-dependent SRF-c-fos activation at promyelocytic leukaemia bodies in the developing brain. Nature Publishing Group UK 2019-12-27 /pmc/articles/PMC6934726/ /pubmed/31882856 http://dx.doi.org/10.1038/s41598-019-56559-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Nagashima, Shun Takeda, Keisuke Shiiba, Isshin Higashi, Mizuho Fukuda, Toshifumi Tokuyama, Takeshi Matsushita, Nobuko Nagano, Seiichi Araki, Toshiyuki Kaneko, Mari Shioi, Go Inatome, Ryoko Yanagi, Shigeru Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies |
title | Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies |
title_full | Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies |
title_fullStr | Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies |
title_full_unstemmed | Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies |
title_short | Critical role of CRAG, a splicing variant of centaurin-γ3/AGAP3, in ELK1-dependent SRF activation at PML bodies |
title_sort | critical role of crag, a splicing variant of centaurin-γ3/agap3, in elk1-dependent srf activation at pml bodies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934726/ https://www.ncbi.nlm.nih.gov/pubmed/31882856 http://dx.doi.org/10.1038/s41598-019-56559-9 |
work_keys_str_mv | AT nagashimashun criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT takedakeisuke criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT shiibaisshin criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT higashimizuho criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT fukudatoshifumi criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT tokuyamatakeshi criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT matsushitanobuko criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT naganoseiichi criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT arakitoshiyuki criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT kanekomari criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT shioigo criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT inatomeryoko criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies AT yanagishigeru criticalroleofcragasplicingvariantofcentauring3agap3inelk1dependentsrfactivationatpmlbodies |